HKSH Symposium on Advances in Cancer Management 2024 Breakthroughs in Cancer Management

January 02, 2025 03:20 PM IST | By Cision
 HKSH Symposium on Advances in Cancer Management 2024 Breakthroughs in Cancer Management
Image source: Kalkine Media

HONG KONG, Jan. 2, 2025 /PRNewswire/ -- HKSH Cancer Centre organised the sixth "HKSH Symposium on Advances in Cancer Management" ("The Symposium") which was held on 12 December 2024 at the HKSH Eastern Building. With the theme "Breakthroughs in Cancer Management", the Symposium attracted approximately 800 healthcare professionals from around the globe to participate both in-person and online. As the HKSH Proton Therapy Centre marks its one-year anniversary, being one of over 120 proton therapy facilities worldwide, several experts from HKSH focused on sharing local experiences with Hong Kong's first proton therapy system in treating major cancers such as head and neck cancer, breast cancer, and paediatric cancer. They also explored groundbreaking advancements combining clinical and research cancer treatments, including MR-guided radiotherapy, genomic profiling in cancer for precision medicine, and latest advances in medical therapy for cancers.

Dr. Walton LI, Chief Executive Officer of the HKSH Medical Group ("HKSH") and Medical Superintendent of Hong Kong Sanatorium & Hospital, highlighted in his opening speech, "After nearly two decades of efforts for the proton therapy project, Hong Kong's first proton therapy system officially commenced service in 2023, marking a significant breakthrough in medical technology for Hong Kong, thanks to the concerted efforts of multiple specialty teams. We hope the Symposium provides a platform for experts from different fields to exchange experiences and new knowledge, thereby striving to improve clinical outcomes in cancer treatment." Dr. LI also mentioned that besides providing clinical services and advancing research, HKSH has been collaborating with the Mayo Clinic in Arizona, USA, to offer specialised proton therapy training for oncology specialists, further establishing Hong Kong's role as a cancer medical hub in the Greater China region.

Mr. Wyman LI, Chief Operating Officer of HKSH Medical Group and Director of Hong Kong Sanatorium & Hospital, emphasised in the closing, "With the opening of the HKSH Proton Therapy Centre, HKSH is now equipped with a full range of world-class advanced cancer radiotherapy systems. Our team has carried out approximately 300 proton therapy cases to date, mainly comprising breast cancer and prostate cancer cases, with paediatric patients making up about ten percent. HKSH will continue to steadily develop proton therapy services to implement treatment plans for major cancers, especially focusing on the needs of paediatric cancer patients to minimise treatment side effects and assist in their healthy growth."

HKSH Cancer Centre, following the launch of proton therapy services, is steadily advancing into a new milestone. Now run on Happy Valley and A Kung Ngam campuses, HKSH Cancer Centre will continue to strive for the best experience for our patients throughout the patient journey with multidisciplinary services, ranging from cancer genetics, diagnostics, rehabilitation to counselling to offer high-quality and reliable medical options and services to cancer patients. Looking ahead, HKSH will host the fifth PTCOG Asia Oceania Congress in November 2025, marking the first international particle therapy academic meeting held in Hong Kong. It is anticipated to attract top global experts to explore innovative treatments, further promote and enhance healthcare standards, and bring hope for treatment to cancer patients.

For more information:
Learn more about HKSH Proton Therapy Centre here
Watch our Proton Therapy video series here

For enquiries, please contact:
Corporate Affairs Department, HKSH Medical Group
[email protected] 


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Limited, Company No. 12643132 (“Kalkine Media, we or us”) and is available for personal and non-commercial use only. Kalkine Media is an appointed representative of Kalkine Limited, who is authorized and regulated by the FCA (FRN: 579414). The non-personalized advice given by Kalkine Media through its Content does not in any way endorse or recommend individuals, investment products or services suitable for your personal financial situation. You should discuss your portfolios and the risk tolerance level appropriate for your personal financial situation, with a qualified financial planner and/or adviser. No liability is accepted by Kalkine Media or Kalkine Limited and/or any of its employees/officers, for any investment loss, or any other loss or detriment experienced by you for any investment decision, whether consequent to, or in any way related to this Content, the provision of which is a regulated activity. Kalkine Media does not intend to exclude any liability which is not permitted to be excluded under applicable law or regulation. Some of the Content on this website may be sponsored/non-sponsored, as applicable. However, on the date of publication of any such Content, none of the employees and/or associates of Kalkine Media hold positions in any of the stocks covered by Kalkine Media through its Content. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content. Some of the images/music/video that may be used in the Content are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music or video used in the Content unless stated otherwise. The images/music/video that may be used in the Content are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.

Top Penny Picks under 20 Cents to Fit Your Pocket! Get Exclusive Report on Penny Stocks For FREE Now.

Recent Articles

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.